MAMMOSCREEN launches the Hereditary Breast Cancer Questionnaire

Calling all women: Be heard and make a difference! 

Are you a healthy woman, someone with a predisposition for hereditary cancer, or a brave fighter facing breast cancer? Your voice matters, and we want to hear it!

 

MammoScreen introduces the Citizen needs about Hereditary Breast Cancer Questionnaire ! 🎗️

 

🌺 What’s it all about? 🌺

 

Our questionnaire focuses on YOU and aims to shed light on the challenges and experiences faced by women like you. We understand that hereditary cancer can impact various aspects of your life, and we’re dedicated to gaining valuable insights to make a real difference.

 

💖 Your impact counts 💖

 

By participating in the questionnaire, you’ll help us explore vital domains like:

 

  • Psychological: Understand the impact on quality of life and coping mechanisms.
  • Health systems & information: Evaluate needs, experiences, and satisfaction with healthcare services.
  • Physical & daily living: Share insights on daily activities and lifestyle modifications.
  • Patient care & support: Assess the support and care you receive, availability of resources, and more.
  • Treatment: Help us explore treatment options, decision-making processes, and preferences.

⌛ Your time matters ⌛

 

We value your time! The questionnaire will take approximately 15 minutes to complete. Don’t worry, you can save your progress and return later to finish it. We kindly ask that you provide responses to the questionnaire before the 15th of September 2023.

 

🎁 Join the movement! 🎁

 

Your participation in the questionnaire can lead to a brighter future for women affected by hereditary breast cancer. Be a part of this meaningful journey – your story matters!

 

📝 Take the Questionnaire NOW: https://tinyurl.com/BreastCancerCitizenSurvey

Share the Post:

You might be interested in

A step forward to improve breast cancer screening: the MammoScreen Lisbon Meeting

Read more

From patients to clinicians: the focus of co-creating an App

Read more

Umbria Bioengineering Technologies (UBT): the engineers of the MammoWave technology  

Read more